|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 764.00 GBX | +0.66% |
|
-1.55% | +3.66% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Premiums and Annuity Revenues | 5.38B | 5.37B | 4.86B | 5.14B | 5.51B | |||||
Total Interest And Dividend Income | 4.49B | 1.95B | 3.38B | 7.36B | 3.53B | |||||
Gain (Loss) on Sale of Investments, Total (Rev) | 12.35B | -38.68B | 11.13B | 7.88B | 18.84B | |||||
Other Revenues, Total | 1B | 951M | 967M | 1.03B | 1.07B | |||||
Total Revenues | 23.22B | -30.4B | 20.34B | 21.41B | 28.96B | |||||
Policy Benefits | 21.87B | -31.24B | 17.56B | 19.78B | 26.65B | |||||
Policy Acquisition / Underwriting Costs, Total | 577M | 505M | 290M | 266M | 238M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 20M | 21M | 6M | 7M | - | |||||
Selling General & Admin Expenses, Total | 2.06B | 2.41B | 1.67B | 1.82B | 1.54B | |||||
Salaries And Other Employee Benefits | 37M | 64M | 109M | 56M | 60M | |||||
Other Operating Expenses | 109M | -492M | 100M | 196M | 189M | |||||
Reinsurance Income Or Expense | 22M | 427M | - | - | - | |||||
Total Operating Expenses | 24.64B | -29.16B | 19.73B | 22.13B | 28.68B | |||||
Operating Income | -1.42B | -1.25B | 606M | -717M | 277M | |||||
Interest Expense, Total | -242M | -230M | -258M | -290M | -266M | |||||
EBT, Excl. Unusual Items | -1.66B | -1.48B | 348M | -1.01B | 11M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Total Merger & Related Restructuring Charges | - | - | -4M | - | - | |||||
Impairment of Goodwill | -47M | - | - | - | - | |||||
Gain (Loss) on Sale of Assets | 87M | - | - | - | - | |||||
Asset Writedown | 1.2B | -1.36B | -390M | -100M | 9M | |||||
Other Unusual Items | - | - | 66M | - | - | |||||
EBT, Incl. Unusual Items | -430M | -2.84B | 20M | -1.11B | 20M | |||||
Income Tax Expense | 279M | -1.08B | 108M | -29M | 414M | |||||
Earnings From Continuing Operations | -709M | -1.76B | -88M | -1.08B | -394M | |||||
Net Income to Company | -709M | -1.76B | -88M | -1.08B | -394M | |||||
Minority Interest | -128M | -67M | -28M | -12M | -49M | |||||
Net Income - (IS) | -837M | -1.83B | -116M | -1.09B | -443M | |||||
Preferred Dividend and Other Adjustments | 23M | 22M | 22M | 29M | 29M | |||||
Net Income to Common Incl Extra Items | -860M | -1.85B | -138M | -1.12B | -472M | |||||
Net Income to Common Excl. Extra Items | -860M | -1.85B | -138M | -1.12B | -472M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.86 | -1.85 | -0.14 | -1.12 | -0.47 | |||||
Basic EPS - Continuing Operations | -0.86 | -1.85 | -0.14 | -1.12 | -0.47 | |||||
Basic Weighted Average Shares Outstanding | 998M | 999M | 1B | 1B | 1B | |||||
Net EPS - Diluted | -0.86 | -1.85 | -0.14 | -1.12 | -0.47 | |||||
Diluted EPS - Continuing Operations | -0.86 | -1.85 | -0.14 | -1.12 | -0.47 | |||||
Diluted Weighted Average Shares Outstanding | 998M | 999M | 1B | 1B | 1B | |||||
Normalized Basic EPS | -1.17 | -0.99 | 0.19 | -0.64 | -0.04 | |||||
Normalized Diluted EPS | -1.17 | -0.99 | 0.19 | -0.64 | -0.04 | |||||
Dividend Per Share | 0.49 | 0.51 | 0.53 | 0.54 | 0.55 | |||||
Payout Ratio | -61.05 | -28.7 | -473.28 | -51.56 | -130.25 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | -1.4B | -1.22B | 625M | -698M | 293M | |||||
EBITA | -1.4B | -1.23B | 612M | -711M | 285M | |||||
EBIT | -1.42B | -1.25B | 606M | -717M | 277M | |||||
EBITDAR | - | - | - | - | - | |||||
Total Revenues (As Reported) | 24.54B | 31.75B | - | - | - | |||||
Effective Tax Rate - (Ratio) | -64.88 | 37.96 | 540 | 2.62 | 2.07K | |||||
Total Current Taxes | 39M | 98M | 122M | 128M | 301M | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | 240M | -1.18B | -14M | -157M | 113M | |||||
Normalized Net Income | -1.17B | -990M | 190M | -641M | -42.12M | |||||
Interest on Long-Term Debt | 242M | 230M | 258M | 290M | 266M | |||||
Non-Cash Pension Expense | 43M | 90M | 137M | -1.06B | 65M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | - | - | - | 49M | |||||
Selling and Marketing Expenses | - | - | - | - | - | |||||
General and Administrative Expenses | 2.06B | 2.41B | 1.67B | 1.82B | 1.54B | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 14M | 16M | 22M | 26M | 26M | |||||
Total Stock-Based Compensation | 14M | 16M | 22M | 26M | 26M |
- Stock Market
- Stocks
- SDLF Stock
- Financials Standard Life plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















